Our products

The TSE technology ensures reversible electroporation and is designed for a safe and simple tumour treatment that spares healthy tissue. IQwave™ is the first CE-marked product developed and produced with the TSE technology.

IQwave™

The TSE technology is built on three patented products: the main TSE unit, IQwave™, the handheld probe and the treatment electrodes. The IQwave system is a completely new generation of electroporation that generates a tumour-specific electrical stimulation. TSE significantly enhances the uptake of various molecules in the intended area where cancer cells are present, thus enabling tumour-specific treatment with very low doses of chemotherapy compared to conventional cancer therapies. TSE’s unique features are designed to reduce unwanted destruction and spare surrounding healthy tissue.

The treatment is multidimensional, which means that the current runs horizontally, vertically and diagonally during the same treatment cycle. The dynamic and multidimensional electrical impulse enhances traditional chemotherapy with a tumour-specific and controlled distribution of the electrical field, enabling coverage of the treated area. Due to this technical solution, IQwave™ can minimize the risk of untreated surfaces without needing more than four electrodes.

Usage and benefits of IQwave™

Using the IQwave™

With IQwave™, we provide physicians with an innovative, non-destructive solution for treating solid superficial tumours of various sizes and locations. Using the customized, adjustable handheld probe, physicians can seamlessly treat both smaller and larger areas with a single device, enhancing precision and improving access to hard-to-reach areas.

IQwave™ and TSE provide significant benefits:

it is gentler through the reduced risk of ablation (burnt/coagulated tissue)
it provides better distribution of electric field to reduce the risk of untreated cancer cells
it is designed as a laptop model for easy handling by physicians
it has a special treatment program for sensitive tissue such as head-, neck- and oral cancer
enables treatment of larger tumours, chemo- and radiation-resistant tumours

IQwave is used with a probe and single-use sterile needle electrodes to diminish the risk of infection due to skin-penetrating electrodes.

TSE: the new and dynamic electroporation

After a thorough medical review of current oncology treatments, an understanding of the limitations of static electroporation, as well as clinical evidence of electroporation’s effectiveness in the treatment of malignant tumours, we have created the first dynamic electroporation that avoids high currents. The entire technology platform is covered by several patents.

Our Products

News & Press releses

Get in touch

Are you interested in our product?

Our team is here to help with any questions about our products, patents or anything else you may need help with.